KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Operating Margin: 2009-2025

Historic Operating Margin for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to 12.83%.

  • Acadia Pharmaceuticals' Operating Margin rose 20.00% to 12.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.01%, marking a year-over-year increase of 1093.00%. This contributed to the annual value of 24.10% for FY2024, which is 3420.00% up from last year.
  • According to the latest figures from Q3 2025, Acadia Pharmaceuticals' Operating Margin is 12.83%, which was up 4.87% from 12.24% recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Operating Margin registered a high of 59.13% during Q4 2024, and its lowest value of -97.88% during Q1 2022.
  • Its 3-year average for Operating Margin is 6.29%, with a median of 12.24% in 2025.
  • Its Operating Margin has fluctuated over the past 5 years, first soared by 5,961bps in 2021, then plummeted by 3,521bps in 2022.
  • Over the past 5 years, Acadia Pharmaceuticals' Operating Margin (Quarterly) stood at -34.15% in 2021, then spiked by 40bps to -33.75% in 2022, then spiked by 4,887bps to 15.12% in 2023, then skyrocketed by 4,401bps to 59.13% in 2024, then increased by 20bps to 12.83% in 2025.
  • Its Operating Margin stands at 12.83% for Q3 2025, versus 12.24% for Q2 2025 and 7.90% for Q1 2025.